Assessment of the synovial fluid interleukin-1 receptor antagonist (IL-1Ra)/interleukin-1 beta (IL-1beta) ratio in patients with osteoarthritis and rheumatoid arthritis.

Pascal Richette(Inserm), F. Rannou(Inserm), Jean‐Marc Cavaillon(Institut Pasteur), Catherine Fitting(Institut Pasteur), Éric Vicaut(Université Paris Cité), Mathias François(The University of Sydney), Jean‐François Savouret(Délégation Paris 5), Thomas Bardin(Institute Mutualiste Montsouris)
Queensland's institutional digital repository (The University of Queensland)
September 1, 2006
Cited by 1

Related Papers

Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial
|The Lancet|2013|1.2k
Successful Cardiopulmonary Resuscitation After Cardiac Arrest as a “Sepsis-Like” Syndrome
|Circulation|2002|1k
Sequential-Design, Multicenter, Randomized, Controlled Trial of Early Decompressive Craniectomy in Malignant Middle Cerebral Artery Infarction (DECIMAL Trial)
|Stroke|2007|867
Dysregulation of in vitro cytokine production by monocytes during sepsis.
|Journal of Clinical Investigation|1991|765
Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes
|New England Journal of Medicine|2013|651